Showing 1 - 2 of 2 trials – Showing only trials currently accepting patients
-
A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)
Stanford is currently accepting patients for this trial. -
Study of Kidney Tumors in Younger Patients
Stanford is currently accepting patients for this trial.